哈三联：关于全资子公司获得政府补助的公告

Group 1 - The company announced that its wholly-owned subsidiary, Lanxi Hasan Pharmaceutical, received a government subsidy of 6 million yuan related to revenue, which accounts for 10.23% of the company's most recent audited net profit attributable to shareholders [2] - The expected increase in total profit for the year 2026 is projected to be 6 million yuan [2]